ferrostatin-1 and 3-methyladenine

ferrostatin-1 has been researched along with 3-methyladenine* in 1 studies

Other Studies

1 other study(ies) available for ferrostatin-1 and 3-methyladenine

ArticleYear
Ferrostatin-1 and 3-Methyladenine Ameliorate Ferroptosis in OVA-Induced Asthma Model and in IL-13-Challenged BEAS-2B Cells.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Ferroptosis was reported to be involved in the occurrence and development of asthma. However, the potential mechanism underlying the role of ferroptosis in asthma remains unclear. In this study, we established the mouse asthma model following the ovalbumin (OVA) method in C57BL/6 mice and the cell model with IL-13 induction in bronchial epithelial cells (BEAS-2B cells). Treatment of ferrostatin-1 (Ferr-1) and 3-methyladenine (3-MA) decreased iron deposition in IL-13-induced BEAS-2B cells and lung tissues of asthma mice, opposite to that in bronchoalveolar lavage fluid (BALF). Meanwhile, excessive lipid peroxidation asthma model

    Topics: Adenine; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cell Line; Cyclohexylamines; Cytokines; Disease Models, Animal; Epithelial Cells; Ferroptosis; Humans; Injections, Intraperitoneal; Interleukin-13; Male; Mice; Mice, Inbred C57BL; Ovalbumin; Oxidative Stress; Phenylenediamines; Signal Transduction

2022